Layered sphere-shaped TiO2 capped with gold nanoparticles on structural defects and their catalysis of formaldehyde oxidation

We describe here a one-step method for the synthesis of Au/TiO₂ nanosphere materials, which were formed by layered deposition of multiple anatase TiO₂ nanosheets. The Au nanoparticles were stabilized by structural defects in each TiO₂ nanosheet, including crystal steps and edges, thereby fixing the Au–TiO₂ perimeter interface. Reactant transfer occurred along the gaps between these TiO₂ nanosheet layers and in contact with catalytically active sites at the Au–TiO₂ interface. The doped Au induced the formation of oxygen vacancies in the Au–TiO₂ interface. Such vacancies are essential for generating active oxygen species (*O⁻) on the TiO₂ surface and Ti^3 + ions in bulk TiO₂. These ions can then form Ti^3 +–O⁻–Ti^4 + species, which are known to enhance the catalytic activity of formaldehyde (HCHO) oxidation. These studies on structural and oxygen vacancy defects in Au/TiO₂ samples provide a theoretical foundation for the catalytic mechanism of HCHO oxidation on oxide-supported Au materials.     

论我国环境法公众参与制度的缺陷及其完善

论述我国环境法的公众参与制度在许多方面存在亟待解决的问题和该制度存在的缺陷以及完善该制度的措施。     

生态足迹模型的缺陷及改进研究进展

从生态足迹的基本理论出发,总结概括了生态足迹假设条件及模型的缺陷：生态偏向性;估算遗漏性;分析静态性;土地“质”的不均衡性。综述了生态足迹分析模型相关问题改进的国内外研究进展,并对今后研究中应加强的几个方面进行了总结。     

环境公益诉讼原告的立法缺陷与完善

随着中国经济的迅速发展,许多侵害公众环境权益事件的频频发生,有些甚至造成了很大的社会影响和国际影响。建立环境公益诉讼制度迫切需要。但中国在环境公益诉讼原告的立法规定上存在缺陷,限制了环境公益诉讼的提起。应该赋予环境保护行政监督主管部门、检察机关、公民、环保社团的环境公益诉讼原告资格,通过环境公益诉讼原告资格的扩展,来维护我们公众的环境权益。     

Amniotic fluid fibrinolytic system in fetal neural tube defects

Second trimester amniotic fluid fibrinolytic system was examined in normal pregnancies and those complicated by anencephaly, spina bifida and fetal chromosome abnormalities. No significant difference was demonstrated between the fibrinolytic systems from normal pregnancies and those complicated by fetal chromosome abnormalities. In pregnancies complicated with anencephaly and spina bifida no significant difference was demonstrated for alpha-1-antitrypsin, alpha-1-antichymotrypsin and urokinase. Plasminogen was significantly lower (p < 0.02) and plasmin significantly higher (p < 0.001) than levels from normal amniotic fluid. Alpha-2-macroglobulin, fibrinogen, FDP-D and FDP-E were detected only in pregnancies complicated with anencephaly and spina bifida.     

Recurrence risk of neural tube defects following a miscarriage

Data from 280 sibships in three published series were used to see if the increased risk of neural tube defect (NTD) associated with having had a miscarriage in the immediately preceding pregnancy was also found in women with a previous affected pregnancy. A statistically significant relative risk of 4.0 (2-tail P=0.0111, Fisher exact test) was found among such women, and this could not be accounted for by the effect of parity or of a history of miscarriage in general. The finding may be useful when counselling patients.     

Detecting neural tube defects by amniocentesis between 11 and 15 weeks' gestation

Forty-two open neural tube defects (NTDs) were identified in our series of 7440 amniocenteses tested between 11 and 15 weeks of gestation. Using a cut-off of ≥2.0 MOM, the detection rate for open NTDs was 95 per cent; 100 per cent each for anencephaly and spina bifida; and 78 per cent for encephalocele. Two encephaloceles had AFP levels less than 2.0 MOM and negative AChEs. Thirty-four (81 per cent) of these NTDs were tested between 13 and 15 weeks and 8 (19 per cent) before 13 weeks. There were 0.6 per cent false positives by AFP (excluding serious abnormalities and fetal death) and 0.1 per cent after AChE. The likelihood of an open NTD after an elevated AFP (≥2.0 MOM) was 24 and 77 per cent for any serious abnormality. These results, when combined with an earlier study, indicate that amniotic fluid AFP appears to be as sensitive a test for open NTDs between 13 and 15 weeks as between 16 and 20 weeks. Additional experience is necessary to determine this before 13 weeks.     

Vitamins,folic acid and neural tube defects: Comments on investigations in the United States

No clear answer concerning whether multivitamin/folate supplementation prevents neural tube defects (NTDs) is provided by three studies in the United States. All these studies are occurrence in nature, no recurrence studies having been conducted. The Atlanta Birth Defects Study is subject to pronounced memory and recall biases, the length between event and interview being as long as 16 years. In a second study (Boston University), objections can be raised to certain aspects of the experimental design, and the claim that 22 per cent of women started vitamins sufficiently early after pregnancy diagnosis to influence NTD formation is suspicious. Our NICHD case control study of 541 women in California and Illinois revealed no evidence for multivitamins or folic acid preventing NTDs. U.S. public policy-makers face difficulties in applying results of recurrence or occurrence studies in high-risk areas to low-risk areas in the U.S.     

The use of amniotic fluid AFP action limits in diagnosing open neural tube defects

An analysis is made of alphafetoprotein (AFP) concentrations in 3630 amniotic fluids submitted for prospective prenatal diagnoses over a 7-year period. There were 89 cases of anencephaly, 74 of open spina bifida and 3467 with normal singleton outcomes. The AFP data were expressed in both standard deviations above the mean and multiples of the normal median for individual weeks of gestation. False positive and false negative rates were comparable in the two systems at selected cut-offs. It is concluded that either system may be used in setting action limits for the primary distinction of unaffected pregnancies from those in which an open neural tube defect is present.